Petauri completes acquisition of Mtech Access and Delta Hat in transformational global expansion
Acquiring Company
Petauri
Acquired Company
Mtech Access
Description
Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of two UK-based firms, Mtech Access and Delta Hat, marking a pivotal moment in its growth trajectory. This transformative expansion enables Petauri to offer more robust and comprehensive capabilities in global market access, evidence generation, and technical specialization, reinforcing its commitment to improving patient outcomes by speeding access to life-changing medical advances.
Quick answer
Petauri is acquiring Mtech Access and Delta Hat, announced June 18, 2024. Petauri is based in Nashville, Tennessee, United States.
- How much did Petauri pay for Mtech Access?
- The deal value was not disclosed.
- What does Petauri do?
- Petauri™ is a purpose-built pharmaceutical services organization.
- Where are Petauri and Mtech Access based?
- Petauri is based in Nashville, Tennessee, United States. Mtech Access is based in Bicester, England, United Kingdom.
- Who are the decision-makers at Petauri?
- Fundz holds 2 contacts at Petauri. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Eximia Research Network completes acquisition of Tidewater Clinical Research to expand its national clinical trial site network (August 2, 2024)
Who to call at Petauri, and when
When Petauri changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Petauri raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Petauri, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Petauri. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Petauri makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Mtech Access?
Mtech Access was acquired by Petauri, based in Nashville. The deal was reported on June 18, 2024. Petauri™ is a purpose-built pharmaceutical services organization. Petauri is privately held and operates in Biotechnology.
When did Petauri acquire Mtech Access?
Petauri's acquisition of Mtech Access was reported on June 18, 2024. Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of two UK-based firms, Mtech Access and Delta Hat, marking a pivotal moment in its growth trajectory. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mtech Access do?
We partner with Pharma and Medtech leaders to drive optimal global commercialisation of their technologies. Our clients benefit from collaborative, expert-driven, solutions-focused partnerships. It is privately held, and is based in Bicester.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.